Standout Papers
- Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial (2015)
- Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial (2002)
- Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial (2017)
Immediate Impact
10 by Nobel laureates 7 from Science/Nature 61 standout
Citing Papers
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
2021 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Works of Paul Sabbatini being referenced
A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
2016
Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Paul Sabbatini | 2484 | 3870 | 1436 | 1837 | 179 | 8.5k | |
| Richard T. Penson | 3208 | 5059 | 1163 | 1251 | 237 | 10.3k | |
| Mark F. Munsell | 1564 | 3527 | 2769 | 2191 | 238 | 11.5k | |
| R. Kreienberg | 1485 | 4223 | 1254 | 1315 | 428 | 10.4k | |
| W. Jonat | 932 | 4579 | 799 | 1693 | 292 | 9.5k | |
| Timothy Perren | 2173 | 2946 | 1289 | 892 | 150 | 6.5k | |
| Clemens Tempfer | 2513 | 1899 | 2064 | 776 | 366 | 8.9k | |
| Diane C. Bodurka | 3824 | 3373 | 2429 | 1042 | 210 | 10.4k | |
| Angeles Alvarez Secord | 3524 | 2216 | 1056 | 721 | 280 | 7.0k | |
| Barbara A. Goff | 5306 | 2322 | 2545 | 1097 | 228 | 9.9k | |
| Martee L. Hensley | 3672 | 4081 | 1572 | 4631 | 220 | 12.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...